prostatic mass
Conditions
Interventions
Gold Standard:The conclusive clinical diagnosis of prostate cancer, inflammation (abscess), BPH or other diseases was made based on the combined consideration of clinical manifestations, PSA level, fu
fine-needle 
for 
Sponsors
Wuhan Fourth Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Cases that obtained approval of the informed consent after sufficient communication; 2. Patients underwent the first prostatic biopsy and obtained the pathological diagnosis. Biopsy indicators: (1) an increase in PSA (higher than 4.0 ng/ml); (2) prostatic nodular or prostate enlargement discovered via digital rectal examination; (3) a space-occupying mass in the prostate discovered via ultrasound, CT, MRI or other imaging examinations. 3. Cases that completed the follow-up and obtained the the conclusive clinical diagnosis.
Exclusion criteria
Exclusion criteria: No
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Puncture biopsy Pathology; | — |
Countries
China
Contacts
Public ContactXiangwu Ding
Department of Gastroenterology, Wuhan Fourth Hospital
Outcome results
None listed